LAB - STANDARD BIOTOOLS INC.

1.01
0.020   1.980%

Share volume: 2,130,825
Last Updated: 05-12-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$0.99
0.02
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
40%
Profitability 35%
Dept financing 23%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.98%
1 Month
14.45%
3 Months
-9.82%
6 Months
-15.83%
1 Year
-11.40%
2 Year
-13.68%
Key data
Stock price
$1.01
P/E Ratio 
4.59
DAY RANGE
$0.98 - $1.01
EPS 
$0.20
52 WEEK RANGE
$0.87 - $1.72
52 WEEK CHANGE
-$5.61
MARKET CAP 
358.593 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,922,849
AVERAGE 30 VOLUME 
$3,122,268
Company detail
CEO: Michael Egholm
Region: US
Website: fluidigm.com
Employees: 620
IPO year: 2011
Issue type:
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems. The company also sells single cell microfluidics that comprise C1 systems; preparatory analytical instruments; and software solutions.

Recent news